Cargando…
PEG3 mutation is associated with elevated tumor mutation burden and poor prognosis in breast cancer
Background: Breast cancer is the second most common malignancy in women and considered as a severe health burden. PEG3 mutations have been observed in several cancers. However, the associations of PEG3 mutation with tumor mutation burden (TMB) and prognosis in breast cancer have not been investigate...
Autores principales: | Zhang, Min, Zhang, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419805/ https://www.ncbi.nlm.nih.gov/pubmed/32729618 http://dx.doi.org/10.1042/BSR20201648 |
Ejemplares similares
-
FAT3 Mutation Is Associated With Tumor Mutation Burden and Poor Prognosis in Esophageal Cancer
por: Guo, Zixin, et al.
Publicado: (2021) -
An miRNA signature associated with tumor mutation burden in endometrial cancer
por: Zhou, Hongyu, et al.
Publicado: (2020) -
Mutations in lysine methyltransferase 2C and PEG3 are associated with
tumor mutation burden, prognosis, and antitumor immunity in pancreatic
adenocarcinoma patients
por: Huang, Yili, et al.
Publicado: (2022) -
Overexpression of prothymosin-α in glioma is associated with tumor aggressiveness and poor prognosis
por: Kumar, Anurag, et al.
Publicado: (2022) -
Tumor mutation burden and recurrent tumors in hereditary lung cancer
por: Hsu, Yi‐Chiung, et al.
Publicado: (2019)